November 6 - 7, 2013
NIA Technical Advisor: Neil Buckholtz (National Institute on Aging)
Organizers: Alan Cross (AstraZeneca), Sonya Dougal (formerly at The New York Academy of Sciences), Howard Feldman (University of British Columbia), Surya Kolluri (Bank of America), Ian Kremer (Leaders Engaged on Alzheimer's Disease), Tetsuyuki Maruyama (Takeda), Richard C. Mohs (Eli Lilly and Company), Jeffrey S. Nye (Janssen R&D), Ronald C. Petersen (Mayo Clinic), Gregory A. Petsko (Weill Cornell Medical College), Andrea Pfeifer (AC Immune), Thomas Rooney (Sanofi), Darryle D. Schoepp (Merck and Company, Inc.), Diane Stephenson (Critical Path Institute), Rudolph E. Tanzi (Harvard Medical School), John Q. Trojanowski (University of Pennsylvania), Diana L. van de Hoef (The New York Academy of Sciences), George Vradenburg (The Global CEO Initiative on Alzheimer's Disease), Michael Weiner (University of California, San Francisco)
This conference will convene leading industry, academic, and government stakeholders to discuss how to prevent and effectively treat Alzheimer's by 2025, by coordinating with governmental efforts to build research resources, reengineer our current drug development and evaluation systems, and identify innovative technologies and financing models. The outcome of this meeting will comprise a research agenda that will delineate the pathways needed to effectively treat and prevent Alzheimer's disease by 2025.
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon R Akabas (Columbia University), Gerald Friedman (The Icahn School of Medicine at Mount Sinai), Martin Kohlmeier (University of North Carolina at Chapel Hill), Charlotte Pratt (National Institutes of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
Friday, May 17, 2013 | 8:00 AM - 4:30 PM
Speakers: Myron S. Cohen (UNC School of Medicine), Chris Collins (amfAR, The Foundation for AIDS Research), Michele R. Decker (Johns Hopkins Bloomberg School of Public Health), Tim Horn (Treatment Action Group), Rick King (IAVI), Luiz Loures (UNAIDS), Mary A. Marovich (NIAID), Nelson L. Michael (Walter Reed Army Institute of Research), Julio Montaner (BC Centre for Excellence in HIV / AIDS), John P. Moore (Weill Cornell Medical College), Robert R. Redfield (University of Maryland School of Medicine), Bill Snow (Global HIV Vaccine Enterprise), Magdalena Sobieszczyk (Columbia University Medical Center), Annie Sparrow (Mount Sinai Global Health), Daniel Tietz (ACRIA), Mitchell Warren (AVAC), Jane Waterman (IAVI)
The UNAIDS "three zeros" strategy provides a clear vision for future HIV / AIDS research and policy. This symposium tackles communication and collaboration, capacity-building for HIV prevention, care, and treatment, vaccine trials and a case study.
Tuesday, April 30, 2013 | 7:00 PM - 8:30 PM
Ivan Oransky (Reuters Health), Harold Garner (Virginia Tech), Morton Meyers (SUNY Stony Brook)
From publish-or-perish to the race for ever-decreasing research dollars, scientists are under pressure to produce new scientific findings. Has the competitive culture of science gone too far? Join us as we try to unweave the web of scientific envy. Part of the Science and the Seven Deadly Sins Series.
Thursday, March 21, 2013 | 6:30 PM - 8:00 PM
Moderator: David Biello (Scientific American)
Speakers: Erle C. Ellis (University of Maryland), Bob Howarth (Cornell University ), Victor Galaz (Stockholm University), Diana Liverman (University of Arizona ), Linus Blomqvist (The Breakthrough Institute)
Organizers: Robert Lalasz (The Nature Conservancy), Michel Wahome (The New York Academy of Sciences)
Leading scientific figures debate whether the best path to sustainability is by stressing limits or innovation.
Edited by Richard S. Ostfeld
and William H. Schlesinger
(Cary Institute of Ecosystem Studies, Millbrook, New York)
The sixth installment of this Annals series presents a diverse collection of timely reviews in conservation biology.
Special Guest Speaker: Thomas Farley (New York City Department of Health and Mental Hygiene)
This eBriefing explores novel HIV prevention programs and therapies among gay, bisexual, and other men who have sex with men.
Organizers: Fritz François (New York University School of Medicine), Mekbib Gemeda (New York University Langone Medical Center), Jo Wiederhorn (Associated Medical Schools of New York), Sonya Dougal (The New York Academy of Sciences), and Brooke Grindlinger (The New York Academy of Sciences)
In this eBriefing, explore ways to incorporate health disparities research and preventative care approaches into the medical school curriculum, attract trainees to health inequity research, and improve the recruitment of minority medical students.
Keynote Speaker: Daniel D. Bikle (University of California, San Francisco and VA Medical Center)
This eBriefing explores the epidemiological data and molecular biology supporting the non-classical effects of vitamin D.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
According to the New York City Panel on Climate Change, global warming could have a big impact on the five boroughs. Three experts discuss the Panel's recent findings, and tell us what weather and policy changes to expect.
Richard Dawkins launches his newest book in the third S&C Provocative Thinkers in Science event. He argues evolution is an indisputable fact, despite nearly half of Americans believing the opposite.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.